NCT05415020Recruiting
Determining the Utility of a Behavioral Intervention in Chronic Migraine
Feasibility, Acceptability, and Pilot Testing of a Behavioral Intervention for Chronic Migraine
Source: ClinicalTrials.gov · Last updated 8 Jun 2026
Brief summary (registry, in English)
This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protocol. Successful completion of this proposal will inform the design of a future full-scale behavioral clinical trial to control chronic migraine.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 8 Jun 2022
- Start date
- 29 Jun 2022
- Primary completion date
- 31 May 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Migraine
- NCT number
- NCT05415020
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 29 Jun 2022 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- other headache disorders including secondary headache disorders
Age
- children younger than 18 years old
Other
- current pregnancy
Who the study is looking for
- have chronic migraine for a minimum of 1-year
- aged 18 years and older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Phoenix | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.